Pfizer (PFE) Receivables - Net (2009 - 2026)
Pfizer's Receivables - Net came in at $12.49 billion for Q2 2026, up 3.4% from $12.08 billion a year earlier but down 0.8% from the prior quarter.
Powered by 
Analysis
Pfizer (PFE) Receivables - Net (2009 - 2026) Analysis & Trends
At the end of FY2025, Pfizer's Receivables - Net was $11.87 billion, up 3.6% from FY2024.
- Receivables - Net carries a five-year compound annual growth rate of 8.5% (FY2020 to FY2025).
- Going back by year, Receivables - Net was $11.46 billion in FY2024 (-0.9%), $11.57 billion in FY2023 (+5.6%), $10.95 billion in FY2022 (-4.6%) and $11.48 billion in FY2021 (+45.1%).
- The five-year range for quarterly Receivables - Net is $10.23 billion (Q2 2023) to $15.16 billion (Q2 2022).
- Year-over-year, Receivables - Net has increased for three consecutive quarters, with growth averaging 3.5% over the last seven quarters.
- The fastest year-over-year change in Receivables - Net over five years came in Q4 2021 (growth of 45.1%), and the weakest in Q2 2023 (a decline of 32.5%).
- Business Quant data shows PFE's Receivables - Net at $12.59 billion (Q1 2026), $11.87 billion (Q4 2025) and $14.26 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.02 Bn | 1,101.60 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 616.49 Bn | 535.01 Bn | 17.26 Bn |
| 3 | AbbVie | 501.09 Bn | 474.20 Bn | 12.70 Bn |
| 4 | Merck | 366.78 Bn | 321.16 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.96 Bn | 261.95 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn |
| 7 | Amgen | 235.44 Bn | 190.84 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.69 Bn | 164.89 Bn | 6.22 Bn |
| 9 | Pfizer | 169.52 Bn | 116.16 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 131.45 Bn | 103.46 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 12.49 Bn |
| Mar 29, 2026 | 12.59 Bn |
| Dec 31, 2025 | 11.87 Bn |
| Sep 28, 2025 | 14.26 Bn |
| Jun 29, 2025 | 12.08 Bn |
| Mar 30, 2025 | 11.85 Bn |
| Dec 31, 2024 | 11.46 Bn |
| Sep 29, 2024 | 14.45 Bn |
| Jun 30, 2024 | 11.39 Bn |
| Mar 31, 2024 | 10.99 Bn |
| Dec 31, 2023 | 11.57 Bn |
| Oct 1, 2023 | 11.09 Bn |
| Jul 2, 2023 | 10.23 Bn |
| Apr 2, 2023 | 12.31 Bn |
| Dec 31, 2022 | 10.95 Bn |
| Oct 2, 2022 | 16.08 Bn |
| Jul 3, 2022 | 15.16 Bn |
| Apr 3, 2022 | 13.23 Bn |
| Dec 31, 2021 | 11.48 Bn |
| Oct 3, 2021 | 11.90 Bn |
API Access
Pfizer Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();